Atlas Trials

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Clinical trial NCT03249480 · UNKNOWN

Trial details

NCT number
NCT03249480
Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Growth Hormone Deficiency
Start date
2015-01-01
Primary completion
2017-08-01
Enrollment
900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.